Attention Deficit Disorder with Hyperactivity
📧 Sign up to get email alerts when something new happens for Attention Deficit Disorder with Hyperactivity.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-14EMA Authorised: Tuzulby (methylphenidate hydrochloride) — Neuraxpharm Pharmaceuticals S.L.
A new methylphenidate hydrochloride product, Tuzulby, has been authorised in the EU for Attention Deficit Disorder with Hyperactivity (ADHD)…